McDonald's, $MCD, is adding more protein to its menu as GLP-1 drugs change how Americans eat.
11% of U.S. adults now take a GLP-1 for weight loss, roughly 28 million people, up from 3% in 2024, per Gallup.
McDonald's says 84% of households with a GLP-1 user still eat there.
McDonald's, $MCD, CEO Chris Kempczinski has said weak traffic and stubborn inflation are becoming the new normal for restaurants.
McDonald's U.S. same-store sales rose just 0.8% last quarter.